HYBRID EVENT: You can participate in person at Rome, Italy or Virtually from your home or work.

2nd International Conference on Orphan Drugs and Rare Diseases

March 13-15, 2025

March 13 -15, 2025 | Rome, Italy
Orphan Drugs 2025

Novel polyphenolic compounds from Mangifera indica as promising alternatives for treating strongyloides stercoralis infections

Speaker at Orphan Drugs and Rare Diseases 2025 - Sergey Shityakov
ITMO University, Russian Federation
Title : Novel polyphenolic compounds from Mangifera indica as promising alternatives for treating strongyloides stercoralis infections

Abstract:

The rapid spread of Strongyloides stercoralis has raised significant public health concerns, affecting more than 600 million individuals globally. With increasing global migration, there is a potential rise in transmission, leading to the urgent need for effective treatment. To investigate ten polyphenolic phytochemicals derived from Mangifera indica as potential alternative therapeutic agents to combat Strongyloides stercoralis infections. The study utilized Density Functional Theory (DFT) analysis, molecular docking, adsorption, distribution, metabolism, excretion, and toxicity (ADMET) assessment, and molecular dynamics (MD) simulations to evaluate the efficacy of these compounds. The electronic structure calculations revealed significant chemical reactivity in compounds such as kaempferol, ellagic acid, quercetin, norathyriol, mangiferin, and ferulic acid. Molecular docking identified mangiferin, quercetin, kaempferol, and norathyriol as promising candidates. Molecular dynamics simulations (100-ns) were performed on the protein-ligand complex, and ADMET screening authenticated these molecules as potential drug candidates. Binding affinity estimation (ΔG) highlighted quercetin and mangiferin as strong inhibitors with binding energies of -42.35 and -54.57 kcal/mol, respectively, compared to a reference compound, thiabendazole (-28.94 kcal/mol). Quercetin and mangiferin have emerged as promising alternatives to thiabendazole, due to their favorable chemical reactivity, potent inhibition, and promising biological activities in treating Strongyloides stercoralis infections.

Biography:

Professor Sergey Shityakov is a distinguished scientist affiliated with the Infochemistry Scientific Center at ITMO University, Russia. His research focuses on molecular pharmacology and computational drug discovery. He has made significant contributions in the development of novel therapeutic agents and drug delivery systems. With numerous publications in high-impact journals, Professor Shityakov continues to lead groundbreaking research in the field of parasitology and pharmaceutical chemistry.

Watsapp